MRCVX
Price
$9.25
Change
+$0.03 (+0.33%)
Updated
Sep 3 closing price
Net Assets
165.4M
PACAX
Price
$11.14
Change
+$0.05 (+0.45%)
Updated
Sep 3 closing price
Net Assets
571.3M
Interact to see
Advertisement

MRCVX vs PACAX

Header iconMRCVX vs PACAX Comparison
Open Charts MRCVX vs PACAXBanner chart's image
MassMutual 20/80 Allocation R3
Price$9.25
Change+$0.03 (+0.33%)
VolumeN/A
Net Assets165.4M
Putnam Dynamic Asset Allocation Cnsrv A
Price$11.14
Change+$0.05 (+0.45%)
VolumeN/A
Net Assets571.3M
MRCVX vs PACAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MRCVX vs. PACAX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRCVX is a Hold and PACAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PACAX has more cash in the bank: 571M vs. MRCVX (165M). PACAX pays higher dividends than MRCVX: PACAX (3.40) vs MRCVX (2.75). MRCVX was incepted earlier than PACAX: MRCVX (11 years) vs PACAX (32 years). MRCVX (1.27) is less costly to investors than PACAX (1.00). PACAX is a more actively managed with annual turnover of: 372.00 vs. MRCVX (16.00). MRCVX (0) and PACAX (0) have matching initial minimum investment requirements. PACAX annual gain was more profitable for investors over the last year : 5.03 vs. MRCVX (4.59). PACAX return over 5 years is better than : 9.30 vs. MRCVX (2.75).
MRCVXPACAXMRCVX / PACAX
Total Expense Ratio1.271.00127%
Annual Report Gross Expense Ratio1.271.00127%
Fund Existence11 years32 years-
Gain YTD5.8676.65488%
Front LoadN/A6%-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets165M571M29%
Annual Yield % from dividends2.753.4081%
Returns for 1 year4.595.0391%
Returns for 3 years14.6920.2273%
Returns for 5 years2.759.3030%
Returns for 10 years26.2227.6495%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMRGX8.120.01
+0.12%
Emerging Markets Equities Fund M
MUESX36.10N/A
N/A
MFS Blended Research Core Equity R2
ETEGX15.27N/A
N/A
Eaton Vance Small-Cap A
SESGX24.63N/A
N/A
Sit ESG Growth S
JEPSX14.08-0.02
-0.14%
JPMorgan Equity Premium Income R5